Does GIVOSIRAN Cause Porphyria acute? 381 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 381 reports of Porphyria acute have been filed in association with GIVOSIRAN (GIVLAARI). This represents 31.1% of all adverse event reports for GIVOSIRAN.
381
Reports of Porphyria acute with GIVOSIRAN
31.1%
of all GIVOSIRAN reports
2
Deaths
245
Hospitalizations
How Dangerous Is Porphyria acute From GIVOSIRAN?
Of the 381 reports, 2 (0.5%) resulted in death, 245 (64.3%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Porphyria acute Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GIVOSIRAN. However, 381 reports have been filed with the FAERS database.
What Other Side Effects Does GIVOSIRAN Cause?
Hospitalisation (141)
Nausea (91)
Product dose omission issue (85)
Fatigue (84)
Therapy interrupted (83)
Pain (74)
Intentional dose omission (63)
Abdominal pain (62)
Vomiting (58)
Malaise (56)
What Other Drugs Cause Porphyria acute?
RITUXIMAB (265)
DICLOFENAC (262)
LEFLUNOMIDE (249)
TOCILIZUMAB (243)
SECUKINUMAB (241)
METHOTREXATE (238)
ACETAMINOPHEN (237)
ADALIMUMAB (236)
PREDNISONE (227)
ALENDRONATE (225)
Which GIVOSIRAN Alternatives Have Lower Porphyria acute Risk?
GIVOSIRAN vs GLASDEGIB
GIVOSIRAN vs GLATIRAMER
GIVOSIRAN vs GLECAPREVIR\PIBRENTASVIR
GIVOSIRAN vs GLEEVEC
GIVOSIRAN vs GLICLAZIDE